Relative effectiveness of augmentation treatments for treatment-resistant depression: a systematic review and network meta-analysis-Reference-Cited by-同舟云学术

Relative effectiveness of augmentation treatments for treatment-resistant depression: a systematic review and network meta-analysis

Published:2020-06-05 Issue:5-6 Volume:32 Page:477-490
ISSN:0954-0261
Container-title:International Review of Psychiatry
language:en
Short-container-title:International Review of Psychiatry

Author:

Carter Ben¹^ORCID,Strawbridge Rebecca²^ORCID,Husain Muhammad Ishrat³⁴^ORCID,Jones Brett D. M.³^ORCID,Short Roxanna⁵^ORCID,Cleare Anthony J.²^ORCID,Tsapekos Dimosthenis²^ORCID,Patrick Fiona²^ORCID,Marwood Lindsey²^ORCID,Taylor Rachael W.²^ORCID,Mantingh Tim²^ORCID,de Angel Valeria²^ORCID,Nikolova Viktoriya L.²^ORCID,Carvalho Andre F.³⁴^ORCID,Young Allan H.²^ORCID

Affiliation:

1. Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London;

2. Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK;

3. Department of Psychiatry, University of Toronto, Toronto, ON, Canada;

4. Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada;

5. Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK

Publisher

Informa UK Limited

Subject

Psychiatry and Mental health

Link

https://www.tandfonline.com/doi/pdf/10.1080/09540261.2020.1765748

Reference58 articles.

1. The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder

2. Astellas Pharmaceutical Industries. (n.d.). Study to evaluate the effect and safety of quetiapine extended release (XR) (FK949E) in major depressive disorder.ClinicalTrials.gov.

3. A Double-Blind Placebo-Controlled Trial of Lamotrigine as an Antidepressant Augmentation Agent in Treatment-Refractory Unipolar Depression

4. A randomised, placebo-controlled 24-week study evaluating adjunctive brexpiprazole in patients with major depressive disorder

5. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thoughtful prescribing for patients with difficult-to-treat depression;Canadian Family Physician;2023-11

2. Plasma Brain-Derived Neurotrophic Factor Levels in First-Episode and Recurrent Major Depression and before and after Bright Light Therapy in Treatment-Resistant Depression;Biomolecules;2023-09-20

3. Predictors of Treatment Response in Patients with Treatment-Resistant Depression: Outcomes of a Randomized Trial;Psychiatry International;2023-08-25

4. Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial;BJPsych Open;2023-07

5. Reliability and validity of the difficult to treat depression questionnaire (DTDQ);Psychiatry Research;2023-06